Abstract:Objectives Café‐au‐lait macules (CALM) are benign birthmarks presenting as uniformly pigmented, well demarcated, brown patches that can be distressing to patients, especially when located in cosmetically sensitive areas. As with all pigmentary lesions in skin of color patients, CALMs have been particularly challenging to treat. Here we present the first case series characterizing treatment parameters and clinical outcomes utilizing the 730‐nm picosecond titanium sapphire laser for the treatment of CALMs. This device provides an additional safe and effective treatment option for these challenging cases. Methods We performed a retrospective review of patients treated at a single institution between April 2021 and December 2023. Clinical photographs were graded by 3 outside board‐certified dermatologists using a 5‐point visual analog scale. Results Fourteen patients (age range: 10 months–66 years, mean age: 27.4 years, Fitzpatrick skin types II–VI) were treated for CALM on the face (11) or body (3). On average, patients received 4.3 treatments, with treatment intervals ranging from 4 to 40 weeks. Treatment remains ongoing with the 730‐nm picosecond laser for eight patients. Overall, patients were rated to have a mean improvement of 26%–50%. Two patients (FST III and VI) achieved 100% clearance after 4‐5 treatment sessions. Our study included four patients whose CALM were of the smooth bordered "coast of California" subtype, three of whom had a mean improvement rating of only 1%–25%. The fourth patient had near complete resolution. Follow up for these patients has ranged from 6 weeks to 1.5 years. Of the patients treated, one patient experienced transient post‐inflammatory hyperpigmentation and another transient post‐inflammatory hypopigmentation, while a third patient experienced mild persistent guttate hypopigmentation. Three patients experienced partial recurrence indicating that maintenance treatments may be needed in some patients. Conclusion The 730‐nm picosecond titanium sapphire laser is a safe and efficacious treatment option, in the right morphologic setting, to improve the cosmetic appearance of CALMs in a wide range of ages and skin types. To our knowledge, this is the first reported treatment of CALMs with picosecond lasers in FST V and VI patients. Our study also supports prior studies which have found that CALM with smooth‐bordered "coast of California" morphology have a poor response to laser therapy as compared to those with jagged or ill‐defined bordered "coast of Maine" morphology.

A Retrospective Study of FQSRL and IPL in the Treatment of Café-au-lait Macule

Comparative Effectiveness of 755-nm Picosecond Laser, 755- and 532-nm Nanosecond Lasers for Treatment of Café-au-Lait Macules (CALMs): A Randomized, Split-Lesion Clinical Trial

Comparative Effectiveness of 755-nm Picosecond Laser, 755-and 532-nm Nanosecond Lasers for Treatment of Cafe-au-Lait Macules (CALMs): A Randomized, Split-Lesion Clinical Trial

Treatment of Café Au Lait Macules in Chinese Patients with a Q-switched 755-Nm Alexandrite Laser.

Laser treatment for Cafe-au-lait Macules: a systematic review and meta-analysis

Treatment of Café‐Au‐Lait Spots Using Q‐Switched Alexandrite Laser: Analysis of Clinical Characteristics of 471 Children in Mainland China

The 730 nm picosecond titanium sapphire laser for treatment of café‐au‐lait macules in all skin types

Use of Reflectance Confocal Microscopy to Predict Treatment Efficacy in Café Au Lait Macules.

Research Progress of Lasers in Treating CALMs

Comparison of the Safety and Efficacy of Low Fluence Q‐switched 1064‐nm and Conventional Q‐Switched 755‐nm Lasers in the Treatment of Café‐au‐lait Macules: A Prospective Self‐controlled Trial

Comparison of efficacy and safety between Q-switched alexandrite laser and intense pulsed light for the treatment of facial freckles

Efficacy and Safety of Fluocinolone Acetonide, Hydroquinone, and Tretinoin Cream in Chinese Patients with Melasma: a Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Study.

A Combination Treatment of Drug‐laser‐photon for Melasma: A Retrospective Study of Clinical Cases

Comparison of 755‐nm picosecond alexandrite laser versus 1064‐nm Q‐switched Nd:YAG laser for melasma: A randomized, split‐face controlled, 2‐year follow‐up study

Topical 5-aminolevulinic acid with intense pulsed light versus intense pulsed light for photodamage in Chinese patients.

Fractional picosecond laser treatment of non‐acne atrophic scars and scar erythema in Chinese patients

Exploring Fractional Pigment Toning: A Novel Approach for Treating Benign Pigmented Lesions in Asian Patients With Fitzpatrick Skin Types III-V

Efficacy and Safety of Fractional Q-switched 1064-Nm Neodymium-Doped Yttrium Aluminum Garnet Laser in the Treatment of Melasma in Chinese Patients.

A Split-Face, Single-Blinded, Randomized Controlled Comparison of Alexandrite 755-Nm Picosecond Laser Versus Alexandrite 755-Nm Nanosecond Laser in the Treatment of Acquired Bilateral Nevus of Ota–like Macules

Comparison of the Efficacy and Safety of Picosecond Nd:YAG Laser (1,064 Nm), Picosecond Alexandrite Laser (755 Nm) and 2% Hydroquinone Cream in the Treatment of Melasma: A Randomized, Controlled, Assessor-Blinded Trial.